NOVONIX Ltd Files 6-K with Appendix 2A
Ticker: NVNXF · Form: 6-K · Filed: Jul 29, 2024 · CIK: 1859795
Sentiment: neutral
Topics: foreign-private-issuer, corporate-update, sec-filing
TL;DR
NOVONIX filed a 6-K on 7/29/24 with Appendix 2A – check for share changes.
AI Summary
NOVONIX Limited filed a Form 6-K on July 29, 2024, reporting its activities for the month of July 2024. The filing includes Exhibit 99.1, which is Appendix 2A, likely related to share issuances or other corporate actions. NOVONIX Limited is incorporated in Australia and its principal executive office is located in Brisbane.
Why It Matters
This filing provides an update on NOVONIX's corporate activities, which could include changes in share structure or other significant events relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves as an update and does not appear to contain significant negative financial news.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- July 29, 2024 (date) — Filing Date
- Appendix 2A (document) — Included Exhibit
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC for the purpose of providing information that the issuer makes or is required to make public pursuant to the laws of its home country or jurisdiction, or that it furnishes or is required to furnish to its security holders.
What is included in Exhibit 99.1 of this filing?
Exhibit 99.1 is described as 'Appendix 2A' in the filing.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
What is the SEC file number for NOVONIX Limited?
The SEC file number for NOVONIX Limited is 001-41208.
Does NOVONIX Limited file annual reports under Form 20-F or 40-F?
NOVONIX Limited indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 197 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-07-29 17:21:43
Filing Documents
- nvx-6k-july-24-07-29-app.htm (6-K) — 18KB
- nvx-ex99_1.htm (EX-99.1) — 71KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-087371.txt ( ) — 92KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: July 29, 2024